Development of postbiotics’ compositions including the evaluation of its bioactivity against pathogenic bacteria and their produced biofilms in the dairy industry

The project's objectives focus on addressing the problem of biofilm formation in the dairy industry, where milk serves as an ideal medium for the growth of microorganisms and the formation of biofilms. Biofilms not only reduce the microbial quality and shelf life of products, but pathogenic microbial biofilms also pose a threat to consumer health and negatively impact the health of milking animals, leading to mastitis and promoting the spread of antibiotic-resistant bacteria. Mature biofilms are difficult to eliminate because they are resistant to traditional detergents and disinfectants. Furthermore, the use of these traditional agents is not only associated with the development of resistance but also with the inactivation of beneficial microbiota and a potential deterioration of the organoleptic properties and nutritional value of dairy products. Thus, various new, safe both for an environment and society methods and agents for limiting biofilm formation in the food production sector are currently being researched worldwide.

This project aims to focus on evaluating the antimicrobial effects of whole inactivated lactic acid bacteria and their metabolites on pathogenic bacteria and the biofilms they produce, developing one or more compositions with antibacterial activity. Recent studies on postbiotics have revealed that they are very stable, do not require a cold chain during storage and transport, and maintain high activity over a long period, thus offering a safer and more cost-effective alternative than live probiotics. Additionally, postbiotics do not induce chemical reactions in food products, do not alter the aroma and taste of the product, do not possess the ability to develop resistance or transfer resistance genes, are not alive, and therefore cannot cause sepsis, making them a safe alternative to probiotics for immunocompromised individuals and infants/newborn animals.

Microorganisms can produce biofilms on any surface, both organic and inorganic, creating threats ranging from contaminated implantable medical devices and cariogenic colonization on tooth enamel to food and water contamination, corrosion of metal surfaces, and equipment clogging, along with other significant health issues due to their wide prevalence and potential harm. Therefore, the application possibilities of postbiotics as a natural, immune-modulating, antibacterial biotechnological product in combating biofilms and planktonic pathogenic bacteria are extensive, and the technology developed in this project for postbiotic extraction and bioactivity evaluation, as well as the compositions created, may also be applicable to solving problems for other target groups.

It is planned that the project will utilize lactic acid bacteria as a source of postbiotics, which are isolated from the milk of healthy cows and/or from traditionally fermented products in Latvia. The research results will be patentable and potentially commercializable.

Project Achievements

Project updates by 30 September 2025

Within the framework of the project’s first activity (WP1) – learning the research methodology and feasibility study – a data management plan has been prepared and a methodology has been developed for the propagation of lactic acid bacteria, cultivation of biofilms, and bacteriological examination of samples. In line with the planned tasks, the necessary materials and reagents have been purchased, and the microbiology and biotechnology laboratory has been set up, including equipment requests and training for working with the new instruments.

At present, several commercially available species of lactic acid bacteria are being cultivated, postbiotics are being extracted, and their antagonistic activity against pathogenic bacteria is being tested. In parallel, training in the cultivation of pathogenic bacteria and Lactobacillus biofilms is ongoing, while the obtained data are already being compiled and supplemented with new experiments in order to begin preparing the first publication soon. Studies on test systems with mammalian cell cultures have also been initiated.

At the same time, the project’s second activity (WP2) – English language training – is being implemented, with one course completed and the next-level course already underway.